Yongan Pharmaceutical (002365.SZ) part of the board of directors plans to collectively reduce their holdings by no more than 235,400 shares.

ChiDirect Financial APP News, Yongan Pharmaceutical (002365.SZ) announced that the company's directors and senior management, Mr. Hong Rengui, Mr. Fang Xiquan, Mr. Wang Zhihua, Mr. Xiong Shengjie, and Mr. Li Shaobo, collectively hold 942,000 shares of the company (representing 0.3197% of the total share capital of the company, and 0.3258% of the total share capital excluding the shares held in the company's repurchase account). They plan to reduce their shareholding by no more than 235,400 shares (0.0799% of the total share capital of the company, and 0.0814% of the total share capital excluding the shares held in the company's repurchase account) through centralized bidding trading within three months after fifteen trading days from the date of the announcement. This reduction will not result in a change in the company's controlling interest.